December 12, 2025 Biomarker Data Repository Workshop First workshop in a series on the Biomarker Data Repository (BmDR). This inaugural workshop will feature presentations on BmDR...
October 30, 2025 Rare/Orphan and Pediatric Disease Program Webinar: Addressing the Lack of Standardized Laboratory Reference Ranges in Neonatal Trials: Pilot GUI Launch C-Path's International Neonatal Consortium hosts the webinar, "Addressing the Lack of Standardized..."
September 25, 2025 International Ataxia Awareness Day: Advancing Hope Through Collaboration and Innovation Every year on September 25, the global community comes together to recognize International Ataxia Awareness Day (IAAD).
September 9, 2025 C-Path’s Global Impact Conference | Every Stage, Every Step: Transforming Lives Through Optimized Drug Development | Day 1 Recap Day 1 of Critical Path Institute's Global Impact Conference, #CGIC2025, opened with powerful conversations on accelerating...
September 7, 2025 World Duchenne Awareness Day: Celebrating 10 Years of D-RSC’s Commitment to Serve the Duchenne Community Today is the World Duchenne Awareness Day (WDAD), an annual event that raises global awareness and understanding of Duchenne...
September 4, 2025 From Data to Hope: C-Path’s Polycystic Kidney Disease Outcomes Consortium and the Power of Data Sharing Every year on September 4, families, patients, advocates, and researchers come together to recognize Polycystic Kidney Disease...
September 8, 2025 Shaping the Future of AATD: Patient Perspectives to Drive the Next Decade of Innovation in Alpha-1 Antitrypsin Deficiency On September 8, C-Path and the Alpha-1 Foundation are co-hosting a virtual workshop, Shaping the Future of AATD: Patient...
July 23, 2025 The Critical Path Institute Podcast: eCOA Conversations on Digital Health Technologies This newest podcast episode from Critical Path Institute’s® (C-Path) Electronic Clinical Outcome Assessment (eCOA) Consortium..
July 16, 2025 Characterizing Tau Accumulation and Amyloid-tau Interactions in the Alzheimer’s Prevention Initiative Autosomal Dominant Alzheimer’s Disease Colombia Trial and Their Implications for Advancing Drug Development
